AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$ALHC

Kent Mark D. purchased $198K of ALHC

Kent Mark D. (President - MSO) purchased 14,848 shares of Alignment Healthcare, Inc. (ALHC) at $13.31 ($0.20M total) on 2026-06-02.

Original reporting
SEC EDGAR · Kent Mark D.
Published Jun 2, 2026, 10:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 11:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ALHC
Bullish
medium confidence
Mentioned
$ALHC
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCBullishLow
01

Why it matters

The disclosure may slightly improve near-term sentiment and can be used as a supportive input for positioning, but it does not change the company’s fundamentals on its own.

02

Market read

A same-day insider open-market buy of ~14,848 shares at ~$13.31/share is a modest positive signal for ALHC sentiment.

03

What to watch

Check whether the officer has a history of buys/sells and whether there are concurrent corporate events (financing, guidance, contracts) not captured in this Form 4.

Relevance 7/10Novelty 6/10Timing: Filed same day as the open-market purchase (2026-06-02).

Background

This is an SEC Form 4 insider transaction disclosure for Alignment Healthcare, Inc., showing an officer/direct purchase.

Company-level read

Ticker impact

$ALHCBullishMedium confidence
Context

Alignment Healthcare officer Kent Mark purchased $197.6K of ALHC shares in an open-market transaction on 2026-06-02.

Expected impact

Likely limited/short-lived impact; any reaction should be small unless accompanied by other news.

Evidence & confidence

The filing provides a concrete buy datapoint (size and date) but no new operational, financial, or deal information; also no 10b5-1 plan is cited.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide policy or competitive signal.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider buys can be routine or driven by personal liquidity/tax planning; without broader fundamentals, follow-through may not materialize.

Key entities

  • issuer
    Alignment Healthcare, Inc.

    Subject of the insider transaction filing (ALHC).

  • insider
    Kent Mark

    President - MSO who reported an open-market purchase of ALHC shares.

Read at source← All news

Related articles

AUG 7
$ALHCMed

Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending?

Alignment Healthcare (ALHC) reported Q2 EPS of 17 cents, up from 7 cents a year earlier, with revenue rising 31.6% to $1.34B and beating consensus. Membership reached about 294,100. The company raised 2026 guidance to $5.195B-$5.225B revenue and 298,000-301,000 membership, but expects lower Q3 adjusted EBITDA ($20M-$30M) due to added clinical, AI and expansion spending.

finance.yahoo.com6 min
AUG 3
$ALHCMed

Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation Into Potential Securities Law Violations

Kaplan Fox said a former Alignment Healthcare executive filed a whistleblower complaint alleging accounting irregularities that allegedly inflated reported and projected results, including Adjusted EBITDA, and misclassified operating expenses as capital expenditures. After the July 8, 2026 report, ALHC shares fell $4.02, or 16.7%, to close at $20.03, according to the article.

theglobeandmail.com3 min
JUL 31
$ALHCMed

Alignment Healthcare (ALHC) Stock Trades Down, Here Is Why

Alignment Healthcare (ALHC) shares fell 14.8% after the company said it will reinvest profits, lowering expected second-half 2026 earnings. On its Q2 2026 call, management raised full-year revenue guidance but expects only about 30% of adjusted EBITDA in the second half, versus 40% a year earlier, due to investment timing.

financialcontent.com3 min
JUL 31
$ALHCHighAI 9/10

Alignment Healthcare (ALHC) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - John E. Kao Chief Financial Officer - James Head TAKEAWAYS Health Plan Membership -- 294,000 members, representing 31% growth year over year. Total Revenue -- $1.3 billion, an increase of 32% year over year driven by membership growth. Adjusted MBR -- 86.3%, an improvement of 40 basis points year over year and the lowest since the company went public.

fool.com6 min
JUL 31
$ALHCHighAI 9/10

Alignment Misses Q2 EPS Estimates

Stock falls 12% in after-hours trading Shares in Alignment Healthcare fell 12% in after-hours trading after reporting second quarter results. Orange-based Alignment, a Medicare Advantage provider for seniors, reported earnings per share (EPS) of 17 cents, missing the 20-cent consensus estimate, according to the TheFly.com. The company’s third-quarter revenue outlook of $1.3 billion to $1.32 billion also came in at the low end of Wall Street estimates.

ocbj.com2 min
JUL 30
$ALHCMedAI 8/10

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops

Health insurance company Alignment Healthcare (NASDAQ: ALHC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 31.6% year on year to $1.34 billion. The company expects next quarter’s revenue to be around $1.31 billion, close to analysts’ estimates. Its GAAP profit of $0.17 per share was 29.8% above analysts’ consensus estimates. Is now the time to buy Alignment Healthcare? Find out by accessing our full research report, it’s free.

financialcontent.com4 min